|
Market Closed -
Nasdaq
23:00:00 21/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 11.18 USD | -1.93% |
|
+1.18% | -45.09% |
| 09-29 | Keros Therapeutics Expects $20 Million Milestone Payment From Takeda | MT |
| 09-29 | Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KROS | Delayed | |
CBOE
| KROS | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 12.07 | 12.07 | 14.46 |
| Spread/Res. | -7.37% | -7.37% | -22.68% |
| Spread/Supp. | +4.88% | +12.82% | +11.13% |
| Support | 10.66 | 9.91 | 10.06 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KROS Stock
- Charts Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
